Categories Earnings, Other Industries

Corning (NYSE: GLW): Q4 2019 Earnings Snapshot

— Corning Incorporated (NYSE: GLW) reported its fourth-quarter 2019 core earnings of $0.46 per share versus $0.44 per share expected.

— Net sales declined by 7% to $2.82 billion versus $2.70 billion expected.

Corning (GLW) Q4 2019 Earnings Snapshot

— Display Technologies sales dropped by 12% due to a decline in display glass volume and prices. Optical Communications sales fell by 23% due to lower volume and reduced production to decrease inventory.

— Environmental Technologies sales jumped by 17%. Specialty Materials sales increased by 14%. Life Sciences sales rose by 8% backed by the strength of new products for cell culture and gene therapy.

— In 2020, the company expects continued growth in Specialty Materials, Environmental Technologies, and Life Sciences.

— The company expects to return to sales and profit growth and expand margins in the second half of 2020 as the volume in Display Technologies and Optical Communications improves.

— Corning expects to add an incremental $3-4 billion in annual sales and improve profitability by the end of 2023 for delivering its strategy and growth framework goals.

— Through 2023, Corning expects to deliver 6-8% compound annual sales growth and 12-15% compound annual EPS growth while investing $10-12 billion in RD&E, capital and mergers, and acquisitions.

— Through 2023, the company plans to expand operating margin and ROIC, and deliver $8-10 billion to shareholders, including annual dividend per share increase of at least 10%.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

Most Popular

CVX Earnings: Chevron reports lower revenue and profit for Q1 2024

Energy exploration company Chevron Corporation (NYSE: CVX) announced first-quarter 2024 financial results, reporting a decline in net profit and revenues. Net income attributable to Chevron Corporation was $5.50 billion or

ABBV Earnings: AbbVie reports lower adj. profit for Q1 2024; revenue edges up

Specialty biopharmaceutical company AbbVie, Inc. (NYSE: ABBV) Friday announced first-quarter 2024 financial results, reporting a decline in adjusted earnings and a modest rise in revenues. The company reported worldwide net

CL Earnings: Key quarterly highlights from Colgate-Palmolive’s Q1 2024 financial results

Colgate-Palmolive Company (NYSE: CL) reported first quarter 2024 earnings results today. Net sales increased 6.2% year-over-year to $5.06 billion. Organic sales increased 9.8%. Net income attributable to Colgate-Palmolive Company was

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top